CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

UI Health

Ian Jasenof, MD, FACOG, MHA, CPE, Mile Square Health Center

The Push for IoT and Improving Clinical Outcomes

Ian Jasenof

Ian Jasenof

The amalgamated system of health care in the United States has created challenges to deliver effective services to its population. According to Shi and Singh (2015), “health care delivery does not function as a rational and integrated network of components designed to work together coherently.” Prior to the signing of the Accountable Care Act in 2010, the Executive Office of the President Council of Economic Advisors in June 2009 composed a report “The Economic Case for Health Care Reform” which reiterated the ongoing deficiencies with the delivery of healthcare services in the United States.


The COVID pandemic has exacerbated chronic disease outcomes as access was impacted or limited due to the patient’s reluctance to sit in crowded waiting rooms and increase their exposure to contract or spread COVID. Use of Telehealth, video, and/or phone visits where provider and patient are in different physical locations has improved access for patients and their providers. Its use only will continue as reimbursement is supported by payors.


Telehealth, telemedicine, and related terms generally refer to the exchange of medical information from one site to another through electronic communication to improve a patient’s health.


What is telemedicine?


Telemedicine is the practice of medicine using technology to deliver care at a distance. A provider in one location uses a telecommunications infrastructure to deliver care to a patient at a distant site.


What is telehealth?


Telehealth refers broadly to electronic and telecommunications technologies and services used to provide care and services at-a-distance


What’s the difference?


Telehealth is different from telemedicine in that it refers to a broader scope of remote health care services than telemedicine. Telemedicine refers specifically to remote clinical services, while telehealth can refer to remote non-clinical services.


Use of Telehealth, video, and/or phone visits where provider and patient are in different physical locations has improved access for patients and their providers


 It is this concept, telemedicine, that needs to be advanced and integrated within the continuum of healthcare for patients and their outcomes. The Internet of Things (IoT) is described as a network of physical devices that uses connectivity to enable the exchange of data. Incorporation of health metrics, such as blood pressure, blood sugar, pulse-oxygenation, and other basic data transmitted and incorporated into the Electronic Medical Record (EMR) can in real-time allow sound clinical decision making for providers.


Limitations and challenges must be considered as we develop and incorporate this paradigm change in healthcare. Connectivity within the EMR is important as well as how the data is interpreted or displayed within the EMR in order to permit clinical decision making. Equally important is the security that is needed to meet HIPAA standards. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) is a federal law that required the creation of national standards to protect sensitive patient health information from being disclosed without the patient's consent or knowledge.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://clinical-trial.lifesciencesreview.com/leadership-perspective/the-push-for-iot-and-improving-clinical-outcomes-nwid-1330.html